Hematopoietic stem cells (HSCs) are long-lasting cells that mature into all types of blood cells: white blood cells, red blood cells and platelets. Almost a trillion new blood cells must be replaced each day to replace normal loss of old blood cells. “Bone Marrow Transplant” is a procedure currently used by clinicians to transplant HSCs and cure a wide range of blood diseases. But not all patients have a suitable donor for a HSC transplant. For the first-time ever, Dr.

Dr. Richard Stone, Professor of Medicine at Harvard University Medical College visits Weill Cornell Medical College. Dr. Stone is pictured here teaching Hematology and Medical Oncology Fellows. 

The Cancer Research and Treatment Fund (CR&T) Board Members visit the research laboratory of Dr. Joseph Scandura, Scientific Director of the Silver MPN Center.

Joseph Scandura, M.D., Ph.D., has been named Scientific Director of the Richard T. Silver, M.D. Myeloproliferative Neoplasms Center at Weill Cornell Medicine. In this newly created position, Dr. Scandura will oversee clinical and basic research targeting myeloproliferative neoplasms (MPNs), a group of diseases causing excessive production of certain blood cells by the bone marrow.